Please see Antenatal Antibody Screen - ABO and Rh(D) group.

This is NOT the NIPT (Percept/Harmony) test

Non-Invasive Prenatal Analysis (NIPA) for Clinically Significant Fetal Antigens is a molecular blood group genotyping assay used to predict the blood group phenotype of the fetus. It is performed for cases where the mother is antigen negative and has a corresponding allo-antibody placing the fetus at risk of being affected by Haemolytic Disease of the Fetus and Newborn (HDFN).

The assay is used to predict the fetal blood group phenotype for the antigens of interest – D, C, c, E, K, k, Fya, Fyb.

Due to the samples short time limit:

Sample MUST be collected Monday to Wednesday only.

Samples MUST reach BHH Lab by 10am on those days.

Any sample collected outside of these times, may be rejected and a recollection required.

Samples must be kept at Room Temperature

Due to the samples short time limit:

Sample MUST be collected Monday to Wednesday only.

Samples MUST reach BHH Lab by 10am on those days.

Any samples collected outside of these times may be rejected and a recollection asked for.

Samples must arrive in QLD within 36 hours of collection.

Samples sent to:  Australian Red Cross Lifeblood QLD

                           44 Musk Ave

                            Kelvin Grove QLD 4059